600 patients66,869 observations120 daysLIVE

Patient P-01701

Synthetic patientNBL-101 · Day 117 · 45–54 · M · baseline S11Open companion preview
Therapy response
Stable
Tolerance
Deteriorating
GI state
Favorable
Inflammatory state
Deteriorating
Nutritional resilience
Favorable
Discontinuation risk
16%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 NBL-101 startedBaseline state S11
  2. Day 12 Trajectory diverged from predictionObserved response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 12.

Primary contributors, last 14 days
  • Inflammatory activity+8
  • Toxicity+8
  • Treatment adherence+5
  • Nutritional resilience+3

What helped?

No interventions yet.

    LIFE OS recommendation
    No intervention is indicated right now. The trajectory is stable relative to similar patients.

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Butyrate / short-chain fatty acid production 60
      • MicrobiomeButyrate capacity 23/100
      • MicrobiomeF. prausnitzii depleted
    • Autonomic recovery 40
      • Wearable2,560 steps/day
      • WearableShort sleep window
    • Inflammatory signalling 15
      • WearableHRV 29 ms, trending down
    DNA
    Fictional pharmacogenomic panel
    • CYP2D6 Intermediate metabolizer
      Expected exposure
    Microbiome
    Shannon diversity 2.4 · butyrate capacity 23/100
    • Akkermansia muciniphilaNormal
    • Faecalibacterium prausnitziiLow
    • Bacteroides fragilisNormal
    • Bifidobacterium longumNormal
    • EnterobacteriaceaeHigh
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    31 ms
    Sleep
    6.4 h
    Steps
    3,181
    Resting HR
    70 bpm
    Daily log: GI score 20, nutritional resilience 66, adherence 93.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Keep meals regular; three to four moderate portions spaced through the day
    • Include a cooked vegetable portion with each main meal
    • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
    • Avoid known triggers for now: fried or oily food, dairy, alcohol
    What to do
    • Log the daily check-in; one line is enough
    • A 15-minute walk after lunch
    • Protect a 7.5-hour sleep window; screens off 30 minutes before
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the scheduled dose as agreed with your care team
    • No additional supplements this week
    • Fictional demo item: continue vitamin D as before

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0178755%S1951
    P-0134652%S12DT-01improved52
    P-0187150%S16HY-01no change57
    P-0188449%S19GI-04no change54
    P-0134248%S11DT-01improved48
    P-0159348%S10HY-01improved56
    P-0180948%S1155
    P-0158546%S1349
    P-0161046%S1456
    P-0181846%S1546
    P-0140445%S0558
    P-0143045%S05CR-01improved54